Psychiatry Weekly 9(3). February 3, 2014

Previous Issue     Archives: -Select Year- 2014 2013 2012 2011 2010 2009 2008 2007 2006 Next Issue

 

• Olfactory Dysfunction: A Potential Biomarker for Schizophrenia Reviewed
• Inquiring Minds: What Patients Want to Know About Their Mental Illness
• Down Syndrome and a Novel Target for an Old Drug: Adrenergic Receptors
• Weight Change Trajectories in Women Diagnosed with PTSD
• What Clinicians Need to Know about Meditation

 

One-Year Mother and Baby Outcomes Following Antipsychotic Use in Pregnancy Gabapentin for Neuroleptic-Induced Akathisia: A Report Adjunctive Anti-Nausea Agent May Improve Fluvoxamine Treatment of OCD

Hippocampal Resting Activity in Schizophrenia: A Biomarker of Cognitive Dysfunction? Following Heart Attack, Moderate Benzodiazepine Use May Have Protective Effects Adjunctive Anti-Nausea Agent May Improve Fluvoxamine Treatment of OCD